We use cookies on our website to provide you with a better service.
More info
Accept all
More options
Functional cookies
Language cookie
Performance cookies
Google Analytics
YouTube
Vimeo
More info
Accept all
Ok
screenreader.back to home
screenreader.open offcanvas menu
Portfolio
Team
News
Contact
back to Capricorn Partners
Capricorn Health
News
rss feed
News
Stay up to date
year
by year
2023
2022
2021
2020
2019
2018
2017
reset
2019
Professor Paul Fitzgerald joins Nexstim’s Scientific Advisory Board
24 April 2019
2018
iSTAR Medical’s MINIject maintains exceptional results in first-in-human trial one year post-surgery (STAR-I)
19 December 2018
UK NICE recommends use of Sequana's alfapump® for the treatment of refractory ascites caused by cirrhosis under special arrangements
15 November 2018
Sequana Medical establishes new corporate headquarters in Ghent, Belgium and raises € 8.5 million from leading Belgian investors including Newton Biocapital, PMV and SFPI-FPIM as well as existing shareholders
15 October 2018
Sequana Medical reports positive data on use of the alfapump® in malignant ascites patients at the International Gynecologic Cancer Society
17 September 2018
Mainstay Medical announces the completion of all implants in the ReActiv8-B Study
9 July 2018
Nexstim Plc – first NBT® system for depression ordered in the US
22 May 2018
iSTAR Medical’s MINIject delivers exceptional 6-month results
15 May 2018
Sequana Medical announces publication of results of multicentre randomized controlled study
19 March 2018
Mainstay Medical announces € 30 million financing new capital to complete US Pivotal ReActiv8-B clinical study and advance european commercialization
15 February 2018
2017
Confo Therapeutics enters into drug discovery collaboration with Roche
19 December 2017
Mainstay Medical announces positive outcome of interim analysis
11 December 2017
1
2
3
4
5